NYSE:BDXMedical Equipment
A Look at Becton Dickinson’s Valuation After Strong Quarterly Results and Upgraded Profit Forecast
Becton Dickinson (NYSE:BDX) just powered through its third-quarter results, with both revenue and profit coming in ahead of expectations. The medical devices maker saw sales surge in its drug-delivery unit, pushing medical revenues up 14%, and management responded by nudging their adjusted profit outlook higher for 2025. This combination of stronger numbers and an upbeat forecast may prompt investors to ask whether the fundamentals are now strong enough to overcome this year’s share price...